About Anthera Pharmaceuticals

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. Anthera has two product candidates, Sollpura, in Phase 3 development for Exocrine Pancreatic Insufficiency due to Cystic Fibrosis and blisibimod, in Phase 2 development for IgA nephropathy.